Antibodies under a microscope

DHH02222

Research Grade Vudalimab

Description

Bispecific, XmAb-20717, XMAB20717, CAS: 2329669-72-7

Targets

Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279, CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4

Isotype/Mimetic

half-IGG1-kappa/(scFv-kappa-heavy)-h-CH2-CH3

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression